Advances in cutaneous squamous cell carcinoma

MCG Winge, LN Kellman, K Guo, JY Tang… - Nature Reviews …, 2023 - nature.com
Human malignancies arise predominantly in tissues of epithelial origin, where the stepwise
transformation from healthy epithelium to premalignant dysplasia to invasive neoplasia …

Squamous-cell carcinoma of the skin

A Wysong - New England Journal of Medicine, 2023 - Mass Medical Soc
Squamous-Cell Carcinoma of the Skin | New England Journal of Medicine Skip to main content
The New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

[HTML][HTML] European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention

AJ Stratigos, C Garbe, C Dessinioti, C Lebbe… - European journal of …, 2020 - Elsevier
Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in
the white populations, accounting for 20% of all cutaneous malignancies. Factors implicated …

British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020

SG Keohane, J Botting, PG Budny… - British Journal of …, 2021 - academic.oup.com
British Association of Dermatologists guidelines for the management of people with cutaneous
squamous cell carcinoma 2020* | British Journal of Dermatology | Oxford Academic Skip to Main …

Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression

P Bailey, RA Ridgway, P Cammareri… - Nature …, 2023 - nature.com
The molecular basis of disease progression from UV-induced precancerous actinic keratosis
(AK) to malignant invasive cutaneous squamous cell carcinoma (cSCC) and potentially …

Management of primary skin cancer during a pandemic: multidisciplinary recommendations

BC Baumann, KM MacArthur, JD Brewer… - Cancer, 2020 - Wiley Online Library
During the coronavirus disease 2019 (COVID‐19) pandemic, providers and patients must
engage in shared decision making regarding the pros and cons of early versus delayed …

[HTML][HTML] Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma

PA Ascierto, D Schadendorf - Journal for Immunotherapy of Cancer, 2022 - ncbi.nlm.nih.gov
Non-melanoma skin cancer (NMSC) includes a wide range of cutaneous tumors, the most
frequent of which are basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma …

[HTML][HTML] Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma

A Wysong, JG Newman, KR Covington… - Journal of the American …, 2021 - Elsevier
Background Current staging systems for cutaneous squamous cell carcinoma (cSCC) have
limited positive predictive value for identifying patients who will experience metastasis …

Therapeutic approaches for Non-melanoma skin Cancer: Standard of Care and Emerging modalities

S Sol, F Boncimino, K Todorova, SE Waszyn… - International Journal of …, 2024 - mdpi.com
Skin cancer encompasses a range of cutaneous malignancies, with non-melanoma skin
cancers (NMSCs) being the most common neoplasm worldwide. Skin exposure is the …

A clinical and biological review of keratoacanthoma

A Tisack, A Fotouhi, C Fidai, BJ Friedman… - British journal of …, 2021 - academic.oup.com
Keratoacanthoma (KA) is a common skin tumour that remains controversial regarding
classification, epidemiology, diagnosis, prognosis and management. Classically, a KA …